TP53 and neoplasm: SIRT2, SIRT7, HDAC1, HDAC2, HDAC3, HDAC6 and HDAC8 can also reduce the acetylation levels of p53, inhibiting cell apoptosis and thereby promoting tumour growth (Table 2).